Full Press Release Details
THERAPEUTICS LIMITED
of this announcement
or other type of issue
number of +securities proposed to be issued for a placement or other type of issue
| ASX +security code | +Security description | Maximum Number of +securities to be issued |
| n/a | Attaching options | 674,694,939 |
| ATH | ORDINARY FULLY PAID | 674,694,939 |
to next page for full details of the announcement
1 - Entity and announcement details
THERAPEUTICS LIMITED
(the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote
any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B
of the ASX Listing Rules.
| 1.2 Registered Number Type | Registration Number |
| ABN | 37080699065 |
1.4 The announcement is
Date of this announcement
1.6 The Proposed issue is:
placement or other type of issue
7 - Details of proposed placement or other issue
- Are any of the following approvals required for the placement or other type of issue?
| +Security holder approval | ||
| Court approval | ||
| Lodgement of court order with +ASIC | ||
| ACCC approval | ||
| FIRB approval | ||
| Another approval/condition external to the entity |
| Approval/Condition | Date for determination | Is the date estimated or actual? | ** Approval received/condition met? | |||
| +Security holder approval | Wednesday November 18, 2020 | Estimated |
| Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? | Will the proposed issue of this +security include an offer of attaching +securities? Yes | |
| Existing class |
of +securities proposed to be issued
+security code and description
: ORDINARY FULLY PAID
of +securities proposed to be issued
the +securities proposed to be issued being issued for a cash consideration?
| In what currency is the cash consideration being paid? | What is the issue price per +security? | |
| AUD - Australian Dollar | AUD 0.03700 |
these +securities rank equally in all respects from their issue date with the existing issued +securities in that class?
the proposed attaching security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing
class' (additional +securities in a class that is already quoted or recorded by ASX)?
+Security - New class (+securities in a class that is not yet quoted or recorded by ASX)
of attaching +securities proposed to be issued
Code (if Issuer is a foreign company and +securities are non CDIs)
| Have you received confirmation from ASX that the terms of the proposed +securities are appropriate and equitable under listing rule 6.1? | Will the entity be seeking quotation of the 'new' class of +securities on ASX? | |
| No | No | |
| ASX +security code | +Security description |
of +securities proposed to be issued
the +securities proposed to be issued being issued for a cash consideration?
describe the consideration being provided for the +securities
provide an estimate of the AUD equivalent of the consideration being provided for the +securities
all the +securities issued in this class rank equally in all respects from their issue date?
| Exercise price | Expiry date |
| AUD 0.0700 | Thursday November 23, 2023 |
of the type of +security that will be issued if the option is exercised
: ORDINARY FULLY PAID
of securities that will be issued if the option is exercised
provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide
the information by separate announcement.
Proposed +issue date
7D - Listing Rule requirements
Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1?
Date of meeting or proposed meeting to approve the issue under listing rule 7.1
Is a party referred to in listing rule 10.11 participating in the proposed issue?
Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules?
Will any of the +securities to be issued be subject to +voluntary escrow?
7E - Fees and expenses
Will there be a lead manager or broker to the proposed issue?
Who is the lead manager/broker?
What fee, commission or other consideration is payable to them for acting as lead manager/broker?
Is the proposed issue to be underwritten?
Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue
7F - Further Information
The purpose(s) for which the entity is issuing the securities
Will the entity be changing its dividend/distribution policy if the proposed issue proceeds?
Any other information the entity wishes to provide about the proposed issue